Tuesday, March 15, 2016

Stillbirths and the ACOG 39 weeks rule----Does it need to be revisited?




The 39-week rule – was established in 2009 that restricts labor induction in the 37th and 38th week of pregnancy (i.e., in the “early-term period”) unless an accepted/approved “indication” is present.

The 39-week rule is now a strict clinical guideline that is enforced by professional organizations, governmental agencies and the medical insurance industry in US. 

In November 2013, ACOG  and Society for Maternal and Fetal medicine(SMFM)  made a recommendation of  replacing the use of “ term”  pregnancy which accommodated gestations between 37 wks to 42 wks with the following designations:
•  Early term: 37 weeks through 38 weeks and 6 days
 •  Full term: 39 weeks through 40 weeks and 6 days
 •  Late term: 41 weeks through 41 weeks and 6 days
 •  Postterm: 42 weeks and beyond

These changes were made by growing research evidence, a part of which has been led by Eunice Kennedy Shriver National Institute of Child Health and Human Development, indicating that key developmental process for the fetus continue well beyond 37 wks till 39 wks. They also advocated that “Babies born at or after 39 weeks have the best chance at healthy outcomes compared to those born before 39 weeks.”

It was seen that the percentage of infants born preterm declined for the seventh straight year in 2013. The NIH  also published a report that shows a decline in induction of labor for singleton birth in year 2011 (23.7%) and 2012 (23.3%),after 20 years of consecutive increases. There was also a decline in Early Elective Deliveries across the United States, from 17% of babies in the United States were delivered before 39 weeks in 2010 to a sharp decline to 4.6% in 2013. 


But, two recent studies, one by Dr. Nicholson presented at Society for Maternal-Fetal Medicine (SMFM) 2016 Pregnancy Meeting and the other by Dr Jason Salemi, assistant professor of family and community medicine at Baylor and lead author of the study advise caution against the universal application of the rule.  

According to  paper presented at SMFM 2016 Pregnancy Meeting Dr Nicholson said that  “Investigators found that the proportion of term stillbirths rose from 1.103 per 1000 deliveries before the rule was adopted to 1.177 per 1000 after. He further added "This study raises the possibility that the 39-week rule may be causing serious unintended harm."

According to Dr Nicholson "Term stillbirth is clearly one of worst obstetrical outcomes, and it occurs with relatively high frequency — in one per 1000 deliveries that reach 37 weeks," he explained. "We should place a high priority on determining the causes, developing preventive interventions, and studying factors suspected of producing this truly horrible outcome.

He advocated an urgent need of high quality research in this area, and until we get the evidence the forced imposition of the 39-week rule should be looked into. The 39 weeks rule was put into action after results of many studies, but he said that all those studies were flawed; they suffered from incorrect modeling, were retrospective cohort studies and the confounders were not corrected for.

He further went to add that "the studies failed to consider ecological fallacy, which is that we should not determine the treatment of an individual patient based on studies that examine population-based data," he said. "Ecological cohort studies should rarely be used to generate policy, yet that's what I think we did."

Dr. Nicholson and his colleagues requested the state health department to provide them with data on term still births and term births segregated according to the weeks of gestation for 3 years before and 3 years after the rule was in enforced. The data clearly showed an increase in deliveries at 39 weeks. He said that "The greatest increases in term stillbirth occurred at 37, 38, and 39 weeks of gestation," he noted, which is "right where the 39-week rule is working."

The team observed a clear increase in number of stillbirths when the rule  was  implemented,  1.103 per 1000 deliveries in 2007-2009 to 1.177 per 1000 in 2011-2013. He further estimated that it accounts for additional 335 more term stillbirths in 2013 than in 2007. He acknowledged some shortcoming of his retrospective cohort study, saying it only identifies association, not causation.

A study published in JAMA paediatric, documented that  during this period admission to NICU increased sharply.

The paper was a topic of hot debate and some physicians suggest that benefit of the rule outweigh the risk. 
Dr. Baxi from New York University Langone Medical Center in New York City Opined that timing of delivery is refined decision depending on many variable and it should be individualized according to the circumstances and not governed by a rule .

She also emphasized the need to understand more about the pathophysiology of the stillbirths. "Unless we know the cause, we can't say it's related to the 39-week rule," Dr Baxi pointed out. "Over time, we have fewer 'unrecognized causes,' but there still are some.

Dr Jason also saw limitations in many studies used to justify the 39-week rule. They conducted a retrospective cohort study, used state health data on  675,000 infants and found equivocal results in elective cesarean sections at 37-38 weeks and those delivered after  39 weeks.

“Each pregnancy is unique,” He said. “I cannot overstate the importance of open and ongoing communication between pregnant women and their healthcare providers so that the potential risks and benefits of any pregnancy-related decision are understood fully.”

Many other studies also have challenged the “39 weeks rule”. A study by Hart et al published in ACOG challenged the application of rule in Women who had prior C-sections. They conclude that their findings suggest the optimal time for scheduled delivery of women with 2 previous cesarean section deliveries is between 38 wks 0 and 38wk 6 days and between 37 wks 0 and 37 wks 6 days for women with ≥ 3 previous cesarean section deliveries

Some physicians said that they do not think that the rule should be dropped entirely but needs to be revisited.



 References:

Hart L, Refuerzo J, Sibai B, Blackwell S. Abstract 40: Should the “39 week rule” apply to women with multiple prior cesarean deliveries? American Journal of Obstetrics & Gynecology 2014; 210(1 Supplement): S27, January 2014
 



Sunday, March 13, 2016

Is the age at natural menopause predictable using Ovarian Reserve Tests or Mother's Age at Menopause? A systemic review.




The first signs of aging are ineludible. The decrease of ovarian function is an important turning point in a woman’s life. But, with current increase in life expectancy women will be expected to live one-third of there lives in this hormone deficient stage.

The average age at final menstruation period (FMP) is 51 years, but menopause occurs between 40-60 years. There is discrepancy between the ability to maintain a normal ovulatory cycle and actual cessation of fertility potential, which is largely  controlled by a set of genes. These genes carry heritable variants, modifying the wide range of ovarian and reproductive aging seen in population based studies.  But, there is a fixed interval of 10 years between the end of fertility and the natural menopause.
 
In recent years we have seen an increase in age- related infertility in women because of postponement of childbirth due to career choices, education, control over fertility, financial concerns, late and second marriages, and infertility.  So, researchers are looking for markers which can accurately predict the end of fertility life span, limiting the number of women unknowingly facing age related infertility. This prediction could also help in timely planning the family or cryopreservation, and decreasing involuntary childlessness.

Currently, no marker has been yet identified that can accurately predict the end of human fertility, hence the final menstrual period is taken as a proxy variable to signify the end of fecundity. Personalized forecast regarding the approximate age at menopause is usually predicted based on age in relation to regularity of cycles.

According to the stages of Reproductive Aging Workshop (STRAW) FSH is very accurate in determining the current state of reproductive aging, but it does not predict the timing of final menstrual period (FMP). Similarly other parameters of Ovarian reserve tests such as antimüllerian hormone (AMH) and antral follicle count (AFC) and levels of inhibin-B lack standardized assays limiting their incorporation and utility as clinical tools for staging reproductive aging.

Researchers also turned towards identifying genetic markers responsible predicting age at natural menopause, but despite identifying potential genetic loci, no dominant alleles responsible for ovarian depletion have been discovered to date. Mother’s age at menopause seems promising to the researchers as it has demonstrated high degree of heritability. Pedigree analysis has shown a dominant pattern of inheritance of natural menopause.

This systemic review was published in February issue of Journal Menopause, aims to evaluate data on prediction of age at natural menopause based on antimüllerian hormone (AMH), antral follicle count (AFC), and mother's ANM so as to use in clinical practice and future research.

The authors conducted three searches and systemic review and included studies up to September 2014, which met the inclusion criteria.
.

Six studies were selected for AMH, out of which 5 were prospective studies and 1 was cross sectional study. These studies had limitations as the levels of AMH were determined by three different assays, and different laboratories making pooling of data impossible. Furthermore, smoking affects the levels of AMH and most of the studies did not correct for it.

For correlating the AFC and predicting age at natural menopause 2 studies were found that met the criteria. AFC measurement was performed on cycle days 2 to 4. It was seen that although in univariate regression AFC showed be promising predictor, when corrected for age and smoking the results were statistically non significant (P=0.13)


Mothers’s ANM is a promising variable in predicting ANM, studies of mother’s ANM consistently stated that among women who had early menopause, their mothers or daughters are highly likely to have early menopause. Daughters of mothers with early menopause also have low levels of AMH and low follicular count.

The studies included have many limitations as only including women with regular cycles, dominance of studies with women of  particular ethnicity,  lack of  including women taking external hormones  and  women with chronic illnesses, such as malignant diseases, genetic diseases, and autoimmune diseases.

The main rationale for predicting ANM is to prevent unwanted childlessness, knowledge of which would encourage women to start family early or to timely cryopreserve eggs.
Knowing mother's age at menopause may be pivotal information for the daughter. Further implications of knowing the ANM will also help in earlier treatment of bone loss and CVDs.

This systematic literature review is the first to use variables AMH, AFC, and mother's ANM in predicting menopause. This review has shown that AMH and mother’s ANM are the most promising variables to be used in daily clinical practice. The models used to predict ANM lack precision at both end of the spectrum and provide wide intervals. A single reading is not capable of predicting the exact age. A large cohort of women with variable age, corrected for smoking and other chronic diseases are followed for a long time with repeated measurements for   AMH and AFC and incorporating mother ANM than a firm conclusion can be drawn. However, all these markers need further research and improvement before they can be applied into day to day clinical practice. At present mother’s ANM seems to be most promising for future research.




References:

http://www.ncbi.nlm.nih.gov/pubmed/3536609
http://newsroom.ucla.edu/releases/researchers-find-a-way-to-predict-244164

Thursday, March 10, 2016

Differentiating between intrauterine pregnancy and cesarean scar pregnancy in the early first trimester by Ultrasongraphy.



Cesarean scar pregnancy (CSP) consists of implantation of the gestational sac in the previous hysterotomy scar, with some serious complications as the pregnancy progresses. 

CSP was first described by Larsen and Salomon in 1978. The incidence currently is 1/1800 to 1/2200 pregnancies with 0.15% of women with previous Caesarean sections ending in CSP. But, as the rates of cesearean section rates are increasing world wide, with some countries reporting as high as 50%, the incidence of CSPs is bound to increase!

Risk factors for  CSPs are those  with a history of multiple Caesarean sections and Caesarean breech delivery but scar pregnancies have also been reported after dilation and curettage, myomectomy, metroplasty, hysteroscopy, and manual removal of the placenta.

In fact up to 72% of cesarean scar pregnancies occur in women who have had 2 or more cesarean deliveries.

Transvaginal Sonography and color Doppler are the best diagnostic tools at present, but the clinician should have a high index of suspicion to use them.

According to a paper by Osborn D.A et al the following sonographic criteria have been put forward for early diagnosis of cesarean scar pregnancies in the first trimester.
  1. Empty uterus with a clearly visualized endometrium;
  2. Empty cervical canal;
  3. Gestational sac within the anterior portion of the lower uterine segment at the presumed site of the cesarean scar; and
  4. Thinned or absent myometrium between the gestational sac and bladder (<5 mm in two-thirds of cases).
  5. Other findings include marked peritrophoblastic color Doppler flow around the sac with low-impedance (pulsatility <1), high-velocity flow (>20 cm/s), a resistive index of less than 0.5, and a peak systolic to diastolic blood flow ratio of less than 3.
MRI being useful as a troubleshooting tool when sonography is equivocal or inconclusive before intervention or therapy.

This paper by  Timor-Tritsch I.E et al in the forthcoming issue of American Journal of Obstetrics & Gynecology describe a sonographic method for the differential diagnosis of CSP vs IUP in early gestation.

The study tests the hypothesis that in a first trimester sonography between 5-10 weeks of pregnancy the relative location of the center of gestational sac to the midpoint of the uterus along a longitudinal line between the external cervical os and the fundus can be used for early detection of CSPs.

This is a retrospective study reviewing the electronic record of 242 ultrasound images from 20004- 2015 were analyzed. A total of 57 cases of CSP diagnosed. The following measurements were made for each case:
  1. distance from the external cervical os to the uterine fundus,
  2. the midpoint axis of the uterus,
  3. the distance from the external cervical os to the center of gestational sacs, and
  4. the distance from the external cervical os to the most distant edge of the gestational sacs from the cervix.

It was seen that the location of the center of gestational sac relative to the midpoint axis of the uterus between 5-10 weeks of gestation differentiated between IUP and CSP (mean 17.8 vs –10.6 mm, respectively, P = .0001).

Most CSPs are located proximally to the midpoint axis of the uterus and most IUPs are located distally to the midpoint axis.

The diagnostic accuracy of the method:  accuracy: sensitivity 93.0% and specificity 98.9%.


The authors strongly believe that the mounting anecdotal evidence supports instituting a simple, relatively inexpensive very early transvaginal screening ultrasound of every pregnant patient with a previous history of cesarean delivery.



References: